Literature DB >> 19421071

Prevalence, risk factors, and impact on outcome of cytomegalovirus replication in serum of Cambodian HIV-infected patients (2004-2007).

Romain Micol1, Philippe Buchy, Gilles Guerrier, Veasna Duong, Laurent Ferradini, Jean-Philippe Dousset, Philippe J Guerin, Suna Balkan, Julie Galimand, Hak Chanroeun, Olivier Lortholary, Christine Rouzioux, Arnaud Fontanet, Marianne Leruez-Ville.   

Abstract

BACKGROUND: In developing countries, the study of cytomegalovirus (CMV) coinfection in HIV-infected patients remains neglected. Quantitative CMV polymerase chain reaction (PCR) is the gold standard diagnostic tool for analyzing serum CMV replication and for predicting CMV disease. We estimated the prevalence of replicating CMV in sera of newly diagnosed HIV-infected Cambodian patients and examined its impact on mortality.
METHODS: This cohort study was based on 2 highly active antiretroviral therapy treatment programs in Cambodia between 2004 and 2007. Quantitative CMV PCR was performed on baseline serum samples of 377 HIV-infected patients.
RESULTS: The prevalence of serum CMV DNA was 55.2% (150 of 272) in patients with CD4 count <100/mm. In multivariate analysis, hemoglobin <9 g/dL, CD4 count <100/mm, and Karnofsky index <50 were independently associated with positive serum CMV DNA at baseline. During a 3-year follow-up period, CMV viral load >or=3.1 log10 copies per milliliter was significantly associated with death independently of CD4 count, other opportunistic infections, and highly active antiretroviral therapy.
CONCLUSIONS: As in industrialized countries, serum CMV replication is highly prevalent among HIV-infected Cambodian patients and is associated with increased mortality. This underscores the importance of diagnostic CMV infection by PCR in sera of HIV-infected patients with CD4 count <100/mm and treating this opportunistic infection to reduce its associated mortality.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19421071     DOI: 10.1097/QAI.0b013e3181a254c2

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  9 in total

1.  Cytomegalovirus Viremia Associated With Increased Mortality in Cryptococcal Meningitis in Sub-Saharan Africa.

Authors:  Caleb Skipper; Mark R Schleiss; Ananta S Bangdiwala; Nelmary Hernandez-Alvarado; Kabanda Taseera; Henry W Nabeta; Abdu K Musubire; Sarah M Lofgren; Darin L Wiesner; Joshua Rhein; Radha Rajasingham; Charlotte Schutz; Graeme Meintjes; Conrad Muzoora; David B Meya; David R Boulware
Journal:  Clin Infect Dis       Date:  2020-07-27       Impact factor: 9.079

2.  CMV retinitis screening and treatment in a resource-poor setting: three-year experience from a primary care HIV/AIDS programme in Myanmar.

Authors:  Nini Tun; Nikolas London; Moe Kyaw Kyaw; Frank Smithuis; Nathan Ford; Todd Margolis; W Lawrence Drew; Susan Lewallen; David Heiden
Journal:  J Int AIDS Soc       Date:  2011-08-15       Impact factor: 5.396

3.  Cytomegalovirus viremia as a risk factor for mortality prior to antiretroviral therapy among HIV-infected gold miners in South Africa.

Authors:  Katherine Fielding; Ai Koba; Alison D Grant; Salome Charalambous; John Day; Cedric Spak; Anna Wald; Meei-Li Huang; Lawrence Corey; Gavin J Churchyard
Journal:  PLoS One       Date:  2011-10-12       Impact factor: 3.240

4.  CMV retinitis in China and SE Asia: the way forward.

Authors:  David Heiden; Peter Saranchuk
Journal:  BMC Infect Dis       Date:  2011-11-24       Impact factor: 3.090

5.  Human cytomegalovirus glycoprotein polymorphisms and increasing viral load in AIDS patients.

Authors:  Xiao-Jing Jiang; Jun Zhang; Yong Xiong; Gerhard Jahn; Hai-Rong Xiong; Zhan-Qiu Yang; Yuan-Yuan Liu
Journal:  PLoS One       Date:  2017-05-03       Impact factor: 3.240

6.  Treating HIV-associated cytomegalovirus retinitis with oral valganciclovir and intra-ocular ganciclovir by primary HIV clinicians in southern Myanmar: a retrospective analysis of routinely collected data.

Authors:  Jillian Murray; Adelene Hilbig; Theint Thida Soe; Win Le Shwe Sin Ei; Kyi Pyar Soe; Iza Ciglenecki
Journal:  BMC Infect Dis       Date:  2020-11-13       Impact factor: 3.090

7.  Human cytomegalovirus infection among treatment-naive HIV-1 infected patients in Ethiopia.

Authors:  Mulugeta Kiros; Alene Geteneh; Henok Andualem; Derbie Alemu; Abebech Tesfaye; Dessalegne Abeje Tefera; Adane Mihret; Dawit Hailu Alemayehu; Andargachew Mulu
Journal:  PLoS One       Date:  2021-02-18       Impact factor: 3.240

8.  Preemptive therapy prevents cytomegalovirus end-organ disease in treatment-naïve patients with advanced HIV-1 infection in the HAART era.

Authors:  Daisuke Mizushima; Takeshi Nishijima; Hiroyuki Gatanaga; Kunihisa Tsukada; Katsuji Teruya; Yoshimi Kikuchi; Shinichi Oka
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

Review 9.  Ongoing burden of disease and mortality from HIV/CMV coinfection in Africa in the antiretroviral therapy era.

Authors:  Emily Adland; Paul Klenerman; Philip Goulder; Philippa C Matthews
Journal:  Front Microbiol       Date:  2015-09-24       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.